About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Increased USFDA Approvals for Indian Drug Firms Result in Better Sale of Drugs in the US

by Reshma Anand on October 13, 2015 at 12:26 PM
Font : A-A+

Increased USFDA Approvals for Indian Drug Firms Result in Better Sale of Drugs in the US

In the second half of the year, India's pharmaceutical industry is expected to see sales and profit growth accelerate, thanks to a pickup in the pace of U.S. approvals for new drugs, offsetting any downturn in volatile emerging markets.

Analysts expect the period between March 2015 and March 2016 to be much better in terms of earnings for the Indian pharmaceutical industry, which has consistently come under attack over manufacturing compliance issues, than the comparable period last year thanks in large part to more FDA drug approvals.

Advertisement

According to analysts at Bank of America Merrill Lynch, 75 approvals were granted to Indian companies between April and September 2015, compared with 72 in the year to March 2015.

Analyst Siddhant Khandekar at ICICI Securities in Mumbai said: "Even though we have seen accelerated approvals from the FDA, that will turn into revenue only in the second half ... The trend of approvals definitely seems positive."
Advertisement

The impact of China's surprise devaluation in August and currency gyrations in Russia and Latin America, key markets for India's $15 billion pharmaceuticals industry, have eaten into revenues at players like Glenmark and Dr Reddy's Laboratories Ltd so far this year.

Other factors which have contributed to declining revenues include China's currency devaluation in August and currency instability in Russia and Latin America.

"The recent approvals should improve growth for most companies, especially Dr Reddy's and Lupin, from the third quarter," Jefferies analysts wrote in a note last week. "But for growth to revert to expected levels, further improvement in approvals is required."

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
Goji Berries May Protect Against Age-Related Vision Loss
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Drugs Banned in India 

Recommended Reading
Generics To Account For 85% Share in the Domestic Pharma Market By 2020
India is likely to be among the top three pharmaceutical markets globally by incremental growth and ...
US Pressure On India's Generic Manufacturing Capacity Threatening Millions of Lives
India is a lifeline for medicines and it has been the leading example globally of the most ......
67th Indian Pharmaceutical Congress to be Held at Mysore from December 19 to 21
More than 10,000 delegates will take part in the event to be organized with the theme Pharmacist ......
Newlink Genetics Receives $18 Million to Upscale Its Research On Potential Ebola Vaccine
Ames-based pharmaceutical company announced that it has received an $18 million from the Biomedical ...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)